The PI3K/Akt pathways play a crucial role in dopaminergic cell survival in PD [27,45], and, therefore, molecules such as rifampicin and resveratrol that act via PI3K/Akt pathways have been investigated as potential therapeutic agents in in vitro models of PD [46,47,48]. The gene discussed is AKT1; the disease is Parkinson disease.